Dr. Michael Ryan Reidy, MD

Dr. Reidy practices at St. Luke's Hospital in Chesterfield, Missouri, part of St. Luke's Episcopal-Presbyterian Hospital.

Dr. Reidy's NPI, 1447575964, was assigned on March 29, 2010. Dr. Reidy graduated from Southern Illinois University School of Medicine in 2010. Dr. Reidy holds Missouri license 2018005681.

Dr. Reidy's primary practice is St. Luke's Hospital, at 232 S Woods Mill Rd, Chesterfield, MO 63017 in St. Louis County. The practice phone is (314) 434-1500.

Dr. Reidy's primary practice is St. Luke's Hospital in Chesterfield, Missouri, part of St. Luke's Episcopal-Presbyterian Hospital. Dr. Reidy is also affiliated with Mercy Hospital South. The medical group on file is St. Luke's Cardiothoracic Surgery. Dmand AI also links Dr. Reidy to 1 more hospital, 2 home health agencies, 1 breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reidy practices, 7 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Reidy's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Reidy is licensed in Missouri.

CMS data shows 425 Medicare services from Dr. Reidy across 16 procedure codes in 2024, for 249 Medicare patients. Medicare paid $114,777 for them.

CMS counts 249 Medicare patients who saw Dr. Reidy in 2024. The largest group is 75 to 84, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reidy's median patient age at 75, with 34% women.

In 2024, Dr. Reidy wrote 209 Medicare Part D claims for 125 patients. 97% of them were for generic drugs. CMS names the drug for 124 of them, across 2 drugs with 11 or more claims each, at $390 in total drug cost. In 2023, CMS named 166 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Reidy for performance year 2024, reported through an alternative payment model (APM). Dr. Reidy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of coronary artery bypass graft (cabg) by Dr. Reidy, more than 89% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 26 papers to Dr. Reidy, published from 2011 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Saccharomyces cerevisiae Proteins, Saccharomyces cerevisiae and Heat-Shock Proteins. Dr. Reidy has published most often in Genetics. Dr. Reidy's most frequent co-authors are Joseph S. Coselli, MD, Ourania A. Preventza, MD and Peter Chang Chen, MD.

CMS Open Payments shows 147 general payments to Dr. Reidy from 29 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 72% of the total. Edwards Lifesciences Corporation paid the most, $3,419.

Dr. Reidy graduated from Southern Illinois University School of Medicine in 2010.